Skip to main content
. 2019 May 31;44(2):661–671. doi: 10.3892/ijmm.2019.4226

Figure 1.

Figure 1

Effect of BTXA on the viability of mouse L929 fibroblasts. (A) The morphological changes of fibroblasts observed under a microscope. (B) The vimentin identification of fibroblasts with Hoechst 33258 was determined by immunofluorescence assay. (C) BTXA inhibited fibroblast viability, which was detected by cell counting kit-8 assay in a dose- (0, 0.125, 0.25, 0.5, 1 and 2 IU/ml) and time- (12, 24 and 48 h) dependent manner. **P<0.01 vs. control. BTXA, botulinum toxin type A.